Using Smart Phone Technology in Detecting the Presence of Atrial Fibrillation
This trial is active, not recruiting.
|Conditions||atrial fibrillation, atrial flutter|
|Treatment||record and transmit heart rhythm|
|Sponsor||The Cleveland Clinic|
|Start date||August 2014|
|End date||October 2016|
|Trial size||60 participants|
|Trial identifier||NCT02214069, 14-612|
The purpose of this study is to examine whether patients can use the AliveCor case to record their heart rhythm and to assess the accuracy of the software in detecting AF vs sinus rhythm
Examine the accuracy of the AliveCor software in detecting AF or sinus rhythm compared to the physician interpretation
time frame: 6 month
Assess the correlation between QT interval derived from the AliveCor device compared to standard 12 lead ECG, as assessed by the overreading electrophysiologists.
time frame: 6 months
All participants from 18 years up to 80 years old.
Inclusion Criteria: 1. Male or female between > 18 and < 80 years of age 2. Paroxysmal or persistent atrial fibrillation 3. Admitted for antiarrhythmic drug loading (Dofetilide or Sotalol) 4. Already has iPhone 4, 4S or 5 with data plan that accommodates the AliveCor case 5. Willing to use the Alive Cor case 6. Written informed consent Exclusion Criteria: 1. Unable or unwilling to use the Alive Cor case for their smart phone 2. Presence of a permanent pacemaker
|Official title||Assessing the Accuracy of an Atrial Fibrillation Detection Algorithm Using Novel Smart Phone Technology in Detecting the Presence of Atrial Fibrillation. iRead Study|
|Principal investigator||Khaldoun Tarakji, MD|
|Description||AliveCor is a new monitoring technology used with a smart phone which allows patients to record their rhythm. The study will compare AliveCor recordings and automated interpretation of the rhythm with the interpretation by an Electrophysiologist.|
Call for more information